Chr. Hansen continues strong momentum with 10% organic growth in Q2
…approvals remain a constraint on market development; the market opportunity long-term is unchanged Full-year outlook for organic growth adjusted to 6-8% (previously 5-8%), free cash flow narrowed upwards to EUR…